1-9 of 9
Richard M. Stone, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Retrospective Multi-Center Analysis of Prognostic Factors Determining Outcomes In Patients with Secondary AML

Sanjay R. Mohan, MD, Jaroslaw P Maciejewski, MD, PhD, FACP, Bindu Tejura, Harry P Erba, DM, PhD, Richard M Stone, M.D., Mikkael A. Sekeres, MD, MS
Journal: Blood
Blood (2010) 116 (21): 2139.
https://doi.org/10.1182/blood.V116.21.2139.2139
Published: 2010
Journal Articles

Peptides Derived From Mutated BCR-ABL Elicit T Cell Immunity In CML Patients

Ann Cai, Derin Keskin, Anselmo Alonso, David DeLuca, Wandi Zhang, Naa Lokko, Valentina Nardi, Richard M Stone, M.D., John Sidney, Vladimir Brusic, Catherine J Wu, MD
Journal: Blood
Blood (2010) 116 (21): 887.
https://doi.org/10.1182/blood.V116.21.887.887
Published: 2010
Journal Articles

Longer-Term Follow up with TG101348 Therapy In Myelofibrosis Confirms Sustained Improvement In Splenomegaly, Disease-Related Symptoms, and JAK2 V617F Allele Burden

Animesh Pardanani, MBBS, PhD, Jason R Gotlib, MD, MS, Catriona Jamieson, MD, PhD, Jorge E. Cortes, MD, Moshe Talpaz, MD, Richard M Stone, M.D., Michael H Silverman, MD, FACP, Jolene Shorr, D. Gary Gilliland, MD, PhD, Ayalew Tefferi, MD
Journal: Blood
Blood (2010) 116 (21): 459.
https://doi.org/10.1182/blood.V116.21.459.459
Published: 2010
Journal Articles

Comparison of High Dose Chemotherapy with Autologous Stem Cell Rescue (ASCT) Versus Consolidation Chemotherapy for Patients < 60 with Cytogenetically Normal AML (CN-AML) and Flt3 ITD

Harshabad Singh, MBBS, Lillian Werner, Daniel J DeAngelo, MD, PhD, Philip C. Amrein, MD, Martha Wadleigh, M.D., Karen K Ballen, MD, Ilene Galinsky, ANP, Donna Neuberg, ScD, Edward Fox, Richard M Stone, M.D., Eyal C Attar, MD
Journal: Blood
Blood (2010) 116 (21): 3555.
https://doi.org/10.1182/blood.V116.21.3555.3555
Published: 2010
Journal Articles

Phase II Study of Bortezomib Added to Standard Daunorubicin and Cytarabine Induction and Dose Escalation of Bortezomib with Intermediate-Dose Cytarabine Consolidation Therapy for Patients with Previously Untreated Acute Myeloid Leukemia Age 60–75 Years: Cancer and Leukemia Group B (CALGB) Study 10502

Eyal C Attar, M.D., Kathleen A. Donohue, M.A., Philip C. Amrein, MD, Martha Wadleigh, MD, Daniel J DeAngelo, MD, PhD, Jonathan E Kolitz, MD, Bayard L. Powell, MD, Peter M Voorhees, M.D., Eunice S. Wang, MD, William Blum, MD, Allison Booth, Richard M Stone, M.D., Barry K Moser, Ph.D., Richard Larson, M.D.
Journal: Blood
Blood (2010) 116 (21): 331.
https://doi.org/10.1182/blood.V116.21.331.331
Published: 2010
Journal Articles

Predictive Factors for All-Trans Retinoic Acid Related Differentiation Syndrome In Acute Promyelocytic Leukemia.

Houry Leblebjian, Pharm.D., Anne McDonnell, Pharm.D., BCOP, J. Andrew Skirvin, Pharm.D., BCOP, Martha Wadleigh, MD, Xiaopan Yao, PhD, MS, Donna Neuberg, ScD, Sylvia Bartel, R.Ph., M.H.P., Daniel J DeAngelo, MD, PhD, Richard M Stone, M.D.
Journal: Blood
Blood (2010) 116 (21): 1052.
https://doi.org/10.1182/blood.V116.21.1052.1052
Published: 2010
Journal Articles

Clinical Outcomes of Acute Promyelocytic Leukemia (APL) Patients According to FLT3 Mutation Status

Harshabad Singh, MBBS, Lillian Werner, Daniel J DeAngelo, MD, PhD, Philip C. Amrein, MD, Martha Wadleigh, M.D., Karen K Ballen, MD, Edward Fox, Ilene Galinsky, ANP, Donna Neuberg, ScD, Richard M Stone, M.D., Eyal C Attar, MD
Journal: Blood
Blood (2010) 116 (21): 2689.
https://doi.org/10.1182/blood.V116.21.2689.2689
Published: 2010
Journal Articles

PKC412 Inhibits the ZNF198-FGFR1 Fusion Tyrosine Kinase and Is Efficacious in Treatment of t(8;13)(p11;q12) Associated Stem Cell Myeloproliferative Disease.

Jing Chen, Ph.D., Daniel J. DeAngelo, M.D., Jeffery L. Kutok, M.D., Ph.D., Ifor R. Williams, M.D., Ph.D., Benjamin H. Lee, M.D., Ph.D., Martha Wadleigh, M.D., Nicole Duclos, Sarah Cohen, Jennifer Adelsperger, Rachel Okabe, Allison Coburn, Ilene Galinsky, Brian J.P. Huntly, M.D., Ph.D., Pamela Cohen, Ph.D., Thomas Meyer, Ph.D., Doriano Fabbro, Ph.D., Lolita Banerji, Ph.D., James D. Griffin, M.D., Sheng Xiao, M.D., Jonathan A. Fletcher, M.D., Richard M. Stone, M.D., D. Gary Gilliland, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 2549.
https://doi.org/10.1182/blood.V104.11.2549.2549
Published: 2004
Journal Articles

Phase I Dose Escalating Trial of Bortezomib (Velcade®) in Combination with Idarubicin and Cytarabine in Patients with Acute Myeloid Leukemia.

Eyal C. Attar, M.D., Daniel J. DeAngelo, M.D., Ph.D., Karen K. Ballen, M.D., Emily Learner, Elizabeth G. Trehu, M.D., David P. Schenkein, M.D., James D. Levine, M.D., Richard M. Stone, M.D., Philip C. Amrein, M.D.
Journal: Blood
Blood (2004) 104 (11): 1799.
https://doi.org/10.1182/blood.V104.11.1799.1799
Published: 2004